117 related articles for article (PubMed ID: 32286106)
1. Serum IGFBP2 Level Is a New Candidate Biomarker of Severe Malnutrition in Advanced Lung Cancer.
Dong J; Zeng Y; Zhang P; Li C; Chen Y; Li Y; Wang K
Nutr Cancer; 2020; 72(5):858-863. PubMed ID: 32286106
[No Abstract] [Full Text] [Related]
2. Serum interleukin-6 levels correlate with malnutrition and survival in patients with advanced non-small cell lung cancer.
Songür N; Kuru B; Kalkan F; Ozdilekcan C; Cakmak H; Hizel N
Tumori; 2004; 90(2):196-200. PubMed ID: 15237582
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor binding protein-2 level is increased in blood of lung cancer patients and associated with poor survival.
Guo C; Lu H; Gao W; Wang L; Lu K; Wu S; Pataer A; Huang M; El-Zein R; Lin T; Roth JA; Mehran R; Hofstetter W; Swisher SG; Wu X; Fang B
PLoS One; 2013; 8(9):e74973. PubMed ID: 24069370
[TBL] [Abstract][Full Text] [Related]
4. Preoperative serum levels of insulin-like growth factor-binding protein 2 predict prognosis of gastric cancer patients.
Hur H; Yu EJ; Ham IH; Jin HJ; Lee D
Oncotarget; 2017 Feb; 8(7):10994-11003. PubMed ID: 28036255
[TBL] [Abstract][Full Text] [Related]
5. Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated malnutrition and muscle wasting.
Dong J; Yu J; Li Z; Gao S; Wang H; Yang S; Wu L; Lan C; Zhao T; Gao C; Liu Z; Wang X; Hao J
J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):704-716. PubMed ID: 33763996
[TBL] [Abstract][Full Text] [Related]
6. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
Jiang AG; Chen HL; Lu HY
BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656
[TBL] [Abstract][Full Text] [Related]
7. Preoperative plasma IGFBP2 is associated with nodal metastasis in patients with penile squamous cell carcinoma.
Hu X; Chen M; Liu W; Li Y; Fu J
Urol Oncol; 2019 Jul; 37(7):452-461. PubMed ID: 31053522
[TBL] [Abstract][Full Text] [Related]
8. Can Inflammatory and Nutritional Serum Markers Predict Chemotherapy Outcomes and Survival in Advanced Stage Nonsmall Cell Lung Cancer Patients?
Cehreli R; Yavuzsen T; Ates H; Akman T; Ellidokuz H; Oztop I
Biomed Res Int; 2019; 2019():1648072. PubMed ID: 30941358
[No Abstract] [Full Text] [Related]
9. Diagnostic accuracy of serum insulin-like growth factor-binding protein 2 for ovarian cancer.
Prayudi PKA; Budiana ING; Mahayasa PD; Surya IGNHW; Wiradnyana AAGP; Suwiyoga K
Int J Gynecol Cancer; 2020 Nov; 30(11):1762-1767. PubMed ID: 32817171
[TBL] [Abstract][Full Text] [Related]
10. Analysis of IGF and IGFBP as prognostic serum biomarkers for adrenocortical carcinoma.
Patel D; Ellis R; Howard B; Boufraqech M; Gara SK; Zhang L; Quezado MM; Nilubol N; Kebebew E
Ann Surg Oncol; 2014 Oct; 21(11):3541-7. PubMed ID: 24833102
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival.
Yang J; Griffiths M; Nies MK; Brandal S; Damico R; Vaidya D; Tao X; Simpson CE; Kolb TM; Mathai SC; Pauciulo MW; Nichols WC; Ivy DD; Austin ED; Hassoun PM; Everett AD
BMC Med; 2020 Oct; 18(1):268. PubMed ID: 33019943
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
[TBL] [Abstract][Full Text] [Related]
13. Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer.
Kendrick ZW; Firpo MA; Repko RC; Scaife CL; Adler DG; Boucher KM; Mulvihill SJ
HPB (Oxford); 2014 Jul; 16(7):670-6. PubMed ID: 24308545
[TBL] [Abstract][Full Text] [Related]
14. Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers.
Akamine T; Takada K; Toyokawa G; Kinoshita F; Matsubara T; Kozuma Y; Haratake N; Takamori S; Hirai F; Tagawa T; Okamoto T; Yoneshima Y; Okamoto I; Shimokawa M; Oda Y; Nakanishi Y; Maehara Y
Surg Oncol; 2018 Mar; 27(1):88-94. PubMed ID: 29549910
[TBL] [Abstract][Full Text] [Related]
15. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
16. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP
J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607
[TBL] [Abstract][Full Text] [Related]
17. Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy.
Tang D; Yao R; Zhao D; Zhou L; Wu Y; Yang Y; Sun Y; Lu L; Gao W
Sci Rep; 2018 Mar; 8(1):3917. PubMed ID: 29500455
[TBL] [Abstract][Full Text] [Related]
18. Relationship of nutritional status and inflammation with survival in patients with advanced cancer in palliative care.
Souza Cunha M; Wiegert EVM; Calixto-Lima L; Oliveira LC
Nutrition; 2018; 51-52():98-103. PubMed ID: 29625409
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
[TBL] [Abstract][Full Text] [Related]
20. Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer.
Ni XF; Wu J; Ji M; Shao YJ; Xu B; Jiang JT; Wu CP
Asia Pac J Clin Oncol; 2018 Dec; 14(6):402-409. PubMed ID: 30178541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]